Oral Hypoglycemic Drugs Concurrent use with chlorpropamide may increase the risk of severe hyponatremia.
Source: FDA drug label - triamterene and hydrochlorothiazide
Brand names: Triamterene And Hydrochlorothiazide
3 interactions on record
Oral Hypoglycemic Drugs Concurrent use with chlorpropamide may increase the risk of severe hyponatremia.
Source: FDA drug label - triamterene and hydrochlorothiazide
Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide. Caution is therefore advised when administering non-steroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.
Source: FDA drug label - triamterene and hydrochlorothiazide
The following agents given together with triamterene may promote serum potassium accumulation and possibly result in hyperkalemia because of the potassium-sparing nature of triamterene, especially in patients with renal insufficiency: blood from blood bank (may contain potassium up to 30 mEq/L of plasma or up to 65 mEq/L of whole blood when stored for more than 10 days); low-salt milk (may contain potassium up to 60 mEq/L); potassium-containing medications (such as parenteral penicillin G potassium); salt substitutes (most contain substantial amounts of potassium).
Source: FDA drug label - triamterene and hydrochlorothiazide